Synthesis and pharmacological evaluation of sulfone substituted HIV protease inhibitors
暂无分享,去创建一个
Paul D. Johnson | Thomas J. Raub | K. Chong | R. R. Hinshaw | S. Thaisrivongs | P. Tomich | G. Bundy | J. Strohbach | J. Lynn | T. Schwartz | G. Padbury | H. Skulnick | L. N. Toth
[1] W. Howe,et al. Structure-based design of sulfonamide-substituted non-peptidic HIV protease inhibitors. , 1995, Journal of medicinal chemistry.
[2] K D Watenpaugh,et al. Structure-based design of nonpeptidic HIV protease inhibitors from a cyclooctylpyranone lead structure. , 1995, Journal of medicinal chemistry.
[3] K. Romines,et al. 4-Hydroxypyrones and related templates as nonpeptidic HIV protease inhibitors , 1995 .
[4] K D Watenpaugh,et al. Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors. , 1994, Journal of medicinal chemistry.
[5] K. Chong,et al. Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro , 1994, Antimicrobial Agents and Chemotherapy.
[6] M. Hanano,et al. Studies on absorption and excretion of drugs. X. Relation between chemical structure and absorption rate. (2). Substituent constant for absorption rate coefficient of foreign organic compounds. , 1968, Chemical & pharmaceutical bulletin.